FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ALBRECHT, D.
Right arrow Articles by VON BOHLEN UND HALBACH, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ALBRECHT, D.
Right arrow Articles by VON BOHLEN UND HALBACH, O.
(The FASEB Journal. 2000;14:925-931.)
© 2000 FASEB

Various effects of angiotensin II on amygdaloid neuronal activity in normotensive control and hypertensive transgenic [TGR(mREN-2)27] rats

DORIS ALBRECHT1, THOMAS NITSCHKE and OLIVER VON BOHLEN UND HALBACH

Institute of Physiology, Faculty of Medicine (Charité), Humboldt University, Tucholskystr. 2, 10117 Berlin, Germany

1Correspondence: Institute of Physiology, Faculty of Medicine (Charité), Humboldt University Berlin, Tucholskystr. 2, 10117 Berlin, Germany. E-mail: doris.albrecht{at}charite.de


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The effects of iontophoretically ejected angiotensin II (Ang II) on the firing rate of neurons in the basolateral complex and the central and cortical amygdala were investigated in two strains of urethane anesthetized rats. In normotensive Sprague-Dawley rats, Ang II induced a significant increase in the discharge rate of responsive amygdaloid neurons. In contrast, in the hypertensive transgenic [TGR(mREN-2)27] rats with higher brain Ang II level, Ang II more often caused inhibitory effects on the amygdaloid firing rate in comparison with controls. The distribution of nonresponsive, excited, and inhibited neurons differed significantly in the two rat strains. Moreover, the responsiveness of amygdaloid neurons was significantly higher in transgenic rats in comparison with controls. Both the increase and the decrease in the firing rate caused by Ang II could be blocked either by angiotensin AT1 or by AT2 receptor-specific antagonists. In many cases, the Ang II-induced decrease in the firing rate was antagonized by bicuculline, a {gamma}-aminobutyric acid (GABAA) antagonist. The higher responsiveness of amygdaloid neurons in transgenic rats as well as the predominance of inhibitory effects, presumedly mediated by GABAergic interneurons, could change the output of the amygdala and its influence on thirst, kidney, and cardiovascular function or on processes of learning and anxiety.—Albrecht, D., Nitschke, T., and Von Bohlen und Halbach, O. Various effects of angiotensin II on amygdaloid neuronal activity in normotensive control and hypertensive transgenic [TGR(mREN-2)27] rats.


Key Words: amygdala • angiotensin II • AT1 • AT2 • bicuculline • extracellular recording • urethane • iontophoresis


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
IT IS NOW widely accepted that a functional renin-angiotensin system is intrinsic to the brain and is of great physiological and pathophysiological importance (1 2 3 4) . Angiotensin II (Ang II) is considered to be one of the most important hormones in the control of blood pressure. It has many of the characteristics of a neurotransmitter (1) . Ang II has equivalent affinity for both of the major Ang II receptor subtypes, namely AT1 and AT2 (2 , 4) . The AT1 receptor mediates many of the known physiological effects of Ang II, among the most prominent being those associated with the cardiovascular system and the kidney. The physiological role of the AT2 receptor has yet to be clearly defined.

Both AT1 (5 , 6) and AT2 receptors (7) were detected within the amygdala. Moreover, AT1A receptor messenger RNA (mRNA) is present in the basolateral amygdala (8) . In addition, nearly all substructures of the amygdala display angiotensin-converting enzyme (ACE) activity (9) . The amygdala is discussed in terms of its role in receiving afferent sensory input and in processing information related to hydromineral balance. Angiotensin acts on and through the amygdala to stimulate thirst and sodium appetite (10) . In addition, the angiotensinergic system seems to play a role in cognition and learning mechanisms by acting on and through the amygdala (11 12 13) . It has also been shown that losartan, an AT1 antagonist, seems to have antianxiety properties in rats (14) . The aim of the present study was to investigate the central effects of Ang II in hypertensive transgenic [TGR(mREN-2)27] rats (15 , 16) , which show higher brain Ang II concentration than Sprague-Dawley (SD) rats (17 , 18) . An enhanced renal vascular responsiveness to Ang II in hypertensive [TGR(mREN-2)27] rats has been shown (19) . The question arose whether in hypertensive transgenic rats an enhanced responsiveness to Ang II might occur in a brain structure involved in the regulation of blood pressure as the amygdala. Therefore, we have compared the effects of iontophoretically ejected Ang II on single unit activity in functionally different subnuclei of the amygdala in normotensive SD and hypertensive transgenic rats. Furthermore, considering the existence of {gamma}-aminobutyric acid (GABAergic) interneurons in the amygdala, we wanted to determine their possible involvement in the effects of Ang II using the GABAA receptor antagonist bicuculline.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Maintenance and preparation of animals
All procedures were carried out according to the institutional standards of animal welfare and approved by the Berlin regional animal ethics committee (G 0260/95). The experiments were performed in two groups of male adult rats: normotensive SD and hypertensive transgenic rats [TGR(mRen2)27]. Heterozygous transgenic rats were obtained by cross-breeding male homozygous transgenic rats with female SD rats. SD as well as transgenic rats were purchased from Møellegard Breeding & Research Center (Ry, Denmark). When experiments were started, the heterozygous TGR(mRen2)27 rats were 10–12 wk old and hypertension was already established. All rats were kept under the same conditions without treatment. Five rats per cage were kept with food and water available ad libitum and on a light-dark diurnal cycle.

Before the experiment, the systolic pressure was determined by tail-cuff plethysmography (Stoelting, Wheat Lane Wood, Ill.). The rats were anesthetized with urethane (1.2 g/kg i.p.) and placed in a stereotaxic instrument. Subsequent injections of urethane were administered as needed (for details see ref 20 ). Rectal temperature was maintained at 37–38°C with a heating pad. The electrocardiogram and the EEG from the visual cortex were monitored to control the level of anesthesia.

Small holes were drilled into the skull at a site 4.5 mm lateral to the midline suture and 6.0 mm anterior to the lambdoid suture. An electrode was lowered 7.5–9.0 mm with a microdrive through the hole to the level of the amygdala.

Recording
Glass microelectrodes for extracellular recording were filled with saturated trypan blue solution (tip resistance 10–30 M{Omega}). The recorded action potentials were amplified and displayed on an oscilloscope and, after passing a window discriminator, (World Precision Instruments, Sarasota, Fla.) were analyzed with the software spike2 (Cambridge Electronic Design, Cambridge, U.K.) running on a personal computer. Standardized pulses corresponding to individual action potentials were used for computing frequency-time histograms that were displayed on-line during sampling. Data were stored on disc for subsequent analysis.

Drugs and iontophoresis
Electrodes for iontophoresis were prepared from 5-barrel micropipettes (World Precision Instruments) with a horizontal puller. The tips were broken under microscopic visualization (tip diameter 5–7 µm). The recording electrode was affixed to the micropipette assembly with a tip separation of 20–40 µm.

The following drugs were used: Ang II (100 µM, pH 4.5; RBI, Natick, Mass.), losartan (LOS; angiotensin AT1 receptor antagonist; 100 µM, pH 8.0; Dupont Merck, Wilmington, Del.), PD 123,319 ditrifluoroacetate (AT2 receptor antagonist; 100 µM, pH 4.5; RBI), (-)-bicuculline methiodide (BIC; GABAA receptor antagonist; 5 mM, pH 3; RBI). Retaining currents (4–10 nA) were applied to the pipettes between drug ejections. In a number of experiments, a barrel filled with sodium chloride (165 mM, pH 4.5 or 8) was used for current balance. No significant contribution from current or pH was detected in control experiments.

Experimental program
Iontophoretic ejection of Ang II was delivered repeatedly during continuous recording of baseline activity. Currents of 20–60 nA were used, in most cases 40 nA. As tachyphylaxis to Ang II is known to occur (21) , and recovery of the surface receptor after removal of the angiotensin agonist occurs with a half-life of 15 min (22) , we ejected angiotensin antagonists concomitant with Ang II at intervals of at least 15 min (longer intervals in most cases) to make sure that the disappearance of Ang II effects in the presence of antagonists was really a blocking effect and not a result of desensitization of receptors. Moreover, we used angiotensin concentrations that were 10x lower than those usually administered in in vivo experiments. The release rate of the barrel should be <17.9 fmol/min/nA in our experiments. This release rate was determined for 1 mM solutions of Ang II (pH 4.5) ejected from 5 barrel glass micropipettes with tip diameters of 4 µm (23) .

After determination of the Ang II-induced effect, either the blocking potency of the AT1 receptor antagonist or of the AT2 receptor antagonist was tested. When inhibitory effects mediated by Ang II were observed, we tried to test whether bicuculline can abolish the Ang II-induced decrease in the discharge rate. Because not all neurons could be studied with a full experimental program, the number of neurons involved differ in the Results section.

Analysis of neuronal responses
Drug responses were compared with control firing frequency recorded immediately before drug application. Based on the continuously recorded rate-meter counts, the average discharge rate of each neuron was evaluated for 120 s before the iontophoresis. This value (referred to as ‘control’) was subtracted from all subsequent changes in firing rate and the results were expressed as ‘% change of control’. If the average change in the discharge rate during the entire response time was >40%, the neuron was considered to be sensitive to the substance applied. This criterion was used to divide the ‘responders’ from the ‘nonresponders’, taking into account the results of statistical trend analysis especially for slowly discharging neurons.

The paired Wilcoxon’s rank-sum test (two-tailed) was used to find out the predominating effect in a neuronal population, comparing the spontaneous firing rate with that during administration of the drugs. The Mann-Whitney U test and the {chi}2 test were used for statistical analysis of differences between both groups of rats (SPSS software). The data are presented in the text as the mean ± SD.

Localization of recording sites
At the end of recording, a small amount of trypan blue was iontophoretically deposited in the brain by passing a 10 µA negative current through the recording electrode for ~10 min. On each side of the brain, recording sites were only stained in one electrode track. The rat was killed with an overdose of urethane and decapitated, and the brain was fixed with 10% formaldehyde. Frontal frozen sections were stained with nuclear red. The location of blue spots within the amygdala was determined.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
The results were obtained from 35 normotensive male SD and 26 hypertensive transgenic male TGR rats. Action potentials were recorded from 164 neurons located in the basolateral complex (lateral, basolateral, and basomedial nucleus) and in the central and cortical amygdala (Table 1 ).


View this table:
[in this window]
[in a new window]
 
Table 1. Responsiveness of neurons in amygdaloid nuclei of Sprague-Dawley and transgenic ratsa

Differences between normotensive controls and hypertensive transgenic rats concerning neuronal firing and the action of Ang II
In general, Ang II could induce excitatory effects (Fig. 1 ) or inhibitory effects (Fig. 2A ). Considering a change in the firing rate of >40% as response, we observed a significant difference in the neuronal responsiveness between the two strains of rats. The proportion of responsive amygdaloid neurons was significantly higher in transgenic rats (41/69 neurons) than in normal animals (40/95 neurons) (P=0.029, {chi}2 test, cross-table). This increase in responsiveness was mainly brought about by an increase in inhibitory effects. The proportion of Ang II-inhibited neurons was higher in transgenic animals in comparison with controls (25/69 vs. 14/95), whereas the percentage of excited neurons in transgenic animals was comparable with that obtained in controls (Table 1) . Thus, the distribution of nonresponsive, excited, and inhibited amygdaloid neurons differed significantly between the two strains of rats (P=0.05, {chi}2 test, cross-table). The difference in the effects could also be demonstrated by statistical analysis of the firing rate of all neurons irrespective of the amount of change. In the amygdala of controls, the predominance of activating effects was significant (P=0.01, Wilcoxon’s rank-sum test, n=95). This was not the case for TGR rats. Despite a greater number of neurons inhibited by Ang II, the Wilcoxon’s rank-sum test did not reach significance level.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 1. Frequency-time histograms. A) The histogram shows that the iontophoretic ejection of Ang II induced a dose-dependent increase in firing of a neuron located in the basolateral amygdala of a Sprague-Dawley (SD) rat. B) Losartan (LOS), an AT1 antagonist, blocked the Ang II-induced effect. About 30 min after the iontophoretic ejection of LOS a diminished response to Ang II could be elicited. C) Coadministration of Ang II and PD 123,319, an AT2 antagonist (PD), did not block the Ang II-induced enhancement in the discharge rate. The iontophoretic ejection of sodium chloride (NaCl) with the same current as the coapplied drugs did not significantly change the discharge rate. The y axes indicate the number of spikes per second, the x axes indicate the time in seconds (bin width = 5 s). The bars represent time and duration of ejection and the numbers show current intensity.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 2. A) The repeated ejection of Ang II induced decreases in the discharge rate of a neuron located in the basolateral amygdala of a transgenic animal (TGR). B) The Ang II-induced inhibitory effect could be blocked by PD 123,319 (PD). The ejection of the AT2 antagonist evoked a long-lasting enhancement of the activity. C) Losartan (LOS) did not effectively antagonize the Ang II-caused inhibition of activity. The y axes indicate the number of spikes per second, and the x axes indicate the time in seconds (bin width = 5 s). The bars represent time and duration of ejection, and the numbers show current intensity.

Analyzing the subdivisions of the amygdala, we also found some differences. A predominant increase in the firing rate caused by Ang II could be observed both in the central as well as in the cortical amygdala of control rats (P=0.019, Wilcoxon’s rank-sum test, n=43). Inhibitory and excitatory effects occurred to nearly the same extent in the basolateral complex (n=52). To the contrary, in transgenic rats the inhibition of the neurons in the basolateral complex significantly predominated (P=0.05, Wilcoxon’s rank-sum test, n=45), whereas for the neuronal group of the cortical and central amygdala (n=24), the result of the Wilcoxon’s rank-sum test was not significant. The data for individual nuclei are given in Table 1 .

Comparing the spontaneous activity of all examined neurons we observed a significant difference between controls and TGRs [0.96±1.83 imp./s (n=95) vs. 2.03±5.86 imp./s (n=69), respectively; P=0.008, Mann-Whitney U test]. It is noteworthy that excitatory effects of Ang II were mainly induced in slowly firing units, whereas inhibitory effects were more frequently obtained in neurons with higher spontaneous discharge rates. Thus, the spontaneous activity of neurons inhibited by Ang II differed significantly from that of neurons excited by Ang II in SD and in transgenic rats (P<0.01, Mann-Whitney U test, see also Fig. 3 ).



View larger version (32K):
[in this window]
[in a new window]
 
Figure 3. Effects of Ang II on the mean (± SE) of firing frequency in amygdaloid neurons (SD, Sprague-Dawley; TGR, transgenic rats). Ang II-excited neurons: means of the discharge rate of neurons increasing their rates by >40%; Ang II-inhibited neurons: means of the discharge rate of cells decreasing their rates by >40%.

There is also a difference between the two groups of rats concerning the duration of the neuronal responses to Ang II. In general, the effects induced by Ang II lasted for several minutes after the end of the iontophoretic ejection. Long-lasting effects were more frequently found in control than in transgenic animals. Thus, in neurons excited by Ang II, significant differences in the duration of the effect could be determined (633±525 s (n=26) vs. 346 ± 329 s (n=16) for controls versus TGRs, respectively; P=0.034, Mann-Whitney U test). The mean iontophoretic current used did not differ in the two strains.

AT1- and AT2-mediated effects of Ang II within the amygdala
As shown in Figs. 2 and 3 , specific AT1 and AT2 angiotensin receptor antagonists blocked the Ang II-induced effects on the firing rate. Losartan antagonized Ang II-induced increases in the firing rate in six neurons, but it also blocked Ang II-induced inhibitions in three neurons. The AT2 antagonist also blocked excitatory (n=2) as well inhibitory effects (n=6) mediated by Ang II. In five neurons recorded in different animals it was possible to test both antagonists. In each case, only one of the angiotensin antagonists blocked the Ang II-induced effect (see Figs. 1 , 2 ). When ejected alone, the AT1 and the AT2 angiotensin receptor antagonists caused changes in the discharge rate in three neurons (two increases, one decrease) and two neurons (increases), respectively. To ensure that the Ang II receptors were not desensitized by a preceding Ang II ejection, angiotensin antagonists were tested no earlier than 15 min after the first administration of Ang II. Therefore, because of the time needed, the blocking potency of the antagonists could be tested only in a small sample of neurons.

In nine neurons located within the basolateral amygdala, it was possible to test the ability of bicuculline to prevent the Ang II-induced decrease in the discharge rate. For the iontophoresis of bicuculline, currents were chosen that did not cause a significant change in the firing rate itself. The GABAA antagonist blocked the inhibition induced by Ang II in seven of these neurons recorded in SD as well as in transgenic rats (Fig. 4 ).



View larger version (13K):
[in this window]
[in a new window]
 
Figure 4. The Ang II-induced decrease in the discharge rate of a neuron located in the central nucleus could be blocked by the GABAA receptor antagonist, bicuculline. The iontophoretic ejection of bicuculline alone with a current of 40 nA did not change the activity. The y axes indicate the number of spikes per second, and the x axes indicate the time in seconds (bin width = 5 s). The bars represent time and duration of ejection, and the numbers show current intensity.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Receptor-dependent effects of Ang II on amygdaloid activity
These results show that Ang II mainly caused an increase in the discharge rate in various subnuclei of the amygdala in SD control rats. This result is in accordance with results obtained in the bed nucleus of the stria terminalis (24) as well as with a recent study on field potentials in the lateral amygdala (25) . Because AT1 and AT2 receptors are present within the amygdala, various effects of Ang II could be mediated dependent on the receptor type activated. As shown in the figures, the Ang II-induced effect in single amygdaloid neurons was mediated either by AT1 or by AT2 receptors. Excitatory effects should be mediated by the stimulation of AT1 receptors. From other brain structures it is known that Ang II induces via AT1 receptors a depolarization of the cell membrane by the involvement of different K+ channels (26 , 27) . In addition, a possible modulation of Ca2+ entry via voltage-dependent Ca2+ channels by Ang II has been examined (26 , 27) . An AT2-mediated opening of potassium channels has been observed in cocultures of brainstem and hypothalamic neurons (28) . Therefore, we would expect an inhibitory action of Ang II by the activation of AT2 receptors. However, the application of Ang II to inferior olivar neurons, which possess only AT2 angiotensin receptors, induced an increase in neuronal discharges (29) . Our results suggest the same excitatory action via AT2 receptors within the amygdala, because PD 123,319 also effectively blocked Ang II-induced increases in the discharge rate. These data as well as our recent study (25) point to an excitatory action of Ang II mediated by AT1 as well as by AT2 receptors in the amygdala. Thus, the direction of the Ang II-induced effects on the firing rate (excitation or inhibition) does not seem to be angiotensin-receptor specific in our study. Further studies are needed to clarify the electrophysiological effect of AT2 receptor stimulation within the amygdala.

Involvement of GABAergic neurons
We suggest that interneurons are involved in mediating suppressive effects of Ang II in both strains of rats. Thus, inhibition of relay cell activity could be explained by Ang II-induced excitation of interneurons. Moreover, as angiotensins are released from the multibarrel electrode like other transmitters (23) , it can be assumed that effects that were presumed to be direct and that arose from local drug diffusion were recorded within a zone with 50 µm radius around the microiontophoretic electrode. There was a distance of 20–40 µm between our recording and the multibarrel electrode. Alterations in activity recorded at the most distal sites were found between 100 and 500 µm, whereas synaptic activity induced by remote drug ejection was seen most frequently within a zone 100–200 µm from the iontophoretic site (30) . Because local circuit interneurons of the basolateral amygdala use GABA as transmitter, we applied bicuculline to investigate whether Ang II-induced inhibitory effects can be blocked by this antagonist. Bicuculline effectively blocked decreases in the discharge rate caused by Ang II. From these experiments it can be concluded that GABAergic interneurons also receive an angiotensinergic innervation. An involvement of GABAergic interneurons in the mediation of inhibitory effects of Ang II was also found in the thalamus (31) . For the cortex it has been also supposed that Ang II might regulate local circuits (8) .

Differences between strains of rats
In transgenic rats we found a higher responsiveness of amygdaloid neurons to Ang II in comparison with SD rats. Considering the function of the amygdala in fear conditioning, it seems to be of interest that TGR(mRen2)27 rats showed a greater anxiogenic profile than control rats (32) . Administration of captopril to TGR(mRen2)27 rats reversed the anxiety-like behavior. Okuyama et al. (33) demonstrated that AT2-deficient mice displayed anxiety-like behavior compared with wild-type mice. Interestingly, in AT2-knockout mice the number of [3H] prazosin sites was significantly reduced in the amygdala. Therefore, it cannot be excluded that the interactions with other neuromodulatory systems, for instance the noradrenergic system, is altered in TGR(mRen2)27 rats.

Although excitatory as well as inhibitory effects mediated by Ang II were found both in normotensive SD and in hypertensive TGR rats, the number of neurons decreasing their firing rate significantly predominated in transgenic animals. The higher percentage of inhibitory effects in transgenic animals might be a result of a stronger innervation of interneurons by angiotensinergic fibers or an up-regulation of receptors to depress the output to brain stem structures. On the other hand, the high concentration of Ang II in transgenic animals (17 , 18) and thus a possible persistent activation of GABAergic neurons might lead to a down-regulation of GABA receptors, explaining the higher baseline activity in hypertensive TGR rats.

As mentioned above, we found significant differences between SD and TGR rats concerning their neuronal responsiveness in the amygdala. A higher responsiveness to Ang II in TGR(mRen2)27 rats has been found in the thalamus in ACE inhibitor-treated transgenic rats in comparison with ACE inhibitor-treated SD controls (34) . An enhanced sensitivity and responsiveness of cardiovascular neurons to Ang II has been also observed in spontaneously hypertensive rats (35) . In addition, it has been shown that water deprivation up-regulates angiotensin AT1 binding and mRNA in rat subfornical organ and anterior pituitary (36) .

Responsiveness of neurons in varioius subnuclei of the amygdala
In a recent immunohistochemical study we have determined the distribution of AT1 receptors within the various subnuclei of the amygdala of female rats (6) . This approach demonstrated high amounts of immunostained cells in the central amygdala. Within the basolateral amygdaloid group, the lateral and basolateral nucleus showed moderate staining, while within the basomedial nucleus of the amygdala only few cells were immunostained. The low responsiveness to Ang II of basomedial neurons in males (compare Table 1 ) corresponds well with the immunocytochemical results we got for females. As Ang II stimulates both AT1 and AT2 receptors, the results of our study correspond well with our fluorescein-coupled Ang II binding study, in which the lateral, the basolateral, and the central nuclei showed an Ang II binding to nearly the same extent (37) .

In summary, the results of this study support the hypothesis that Ang II plays a role as a neuromodulator in the amygdala. Thus, Ang II influences not only the striatal parts (38) of the amygdala (central and cortical nuclei) that are involved in the regulation of vegetative functions, but also the cortical part of the amygdala (basolateral complex), which seems to be involved in cognitive functions (39) . The results also suggest that alterations in the renin-angiotensin system might change the network properties within the amygdala.


   ACKNOWLEDGMENTS
 
The authors wish to thank Dr. O. Jöhren for critically reading the manuscript. The authors would like to thank Dr. R. D. Smith (Dupont Merck) for providing losartan. The authors also thank Mrs. Ursula Seider and Mr. Roland Schneider for their excellent technical assistance. This study was supported by the Deutsche Forschungsgemeinschaft (grant INK21/B7 and Al 342/7–1).


   FOOTNOTES
 
Received for publication August 4, 1999. Revised for publication November 22, 1999.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Phillips, M. I. (1987) Functions of angiotensin in the central nervous system. Annu. Rev. Physiol. 49,413-435[Medline]
  2. Saavedra, J. M. (1992) Brain and pituitary angiotensin. Endocr. Rev. 13,329-380[Medline]
  3. Sumners, C., Raizada, M. K., Kang, J., Lu, D., Posner, P. (1994) Receptor-mediated effects of angiotensin-II on neurons. Front. Neuroendocrinol. 15,203-230[Medline]
  4. Wright, J. W., Krebs, L. T., Stobb, J. W., Harding, J. W. (1995) The angiotensin IV system: functional implications. Front. Neuroendocrinol. 16,23-52[Medline]
  5. Song, K., Allen, A. M., Paxinos, G., Mendelsohn, F. A. (1992) Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J. Comp. Neurol. 316,467-484[Medline]
  6. von Bohlen und Halbach, O., Albrecht, D. (1998) Mapping of angiotensin AT1 receptors in the rat limbic system. Regul. Pept. 78,51-56[Medline]
  7. Reagan, L. P., Flanagancato, L. M., Yee, D. K., Ma, L. Y., Sakai, R. R., Fluharty, S. J. (1994) Immunohistochemical mapping of angiotensin type-2 (AT2) receptors in rat brain. Brain Res 662,45-59[Medline]
  8. Jöhren, O., Saavedra, J. M. (1996) Expression of AT1A and AT1B angiotensin II receptor messenger RNA in forebrain of 2-wk-old rats. Am. J. Physiol. 271,E104-E112[Abstract/Free Full Text]
  9. Chai, S. Y., Mendelsohn, F. A. O., Paxinos, G. (1987) Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience 20,615-627[Medline]
  10. Johnson, A. K., Thunhorst, R. L. (1997) The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front. Neuroendocrinol. 18,292-353[Medline]
  11. Barnes, J. M., Barnes, N. M., Costall, B., Coughlan, J., Kelly, M. E., Naylor, R. J., Tomkins, D. M., Williams, T. J. (1992) Angiotensin-converting enzyme-inhibition, angiotensin, and cognition. J. Cardiovasc. Pharmacol. 19,S63-S71
  12. von Bohlen und Halbach, O., Albrecht, D. (1997) Angiotensin inhibits the induction of long-term potentiation within the lateral amygdala. Peptides 19,1031-1036
  13. Winnicka, M. M., Boguszewicz, J., Braszko, J. (1988) Lesions of central amygdala abolish angiotensin II improvement of recall in passive avoidance situation. Pol. J. Pharmacol. Pharm. 40,129-134[Medline]
  14. Kaiser, F. C., Palmer, G. C., Wallace, A. V., Carr, R. D., Fraserrae, L., Hallam, C. (1992) Antianxiety properties of the angiotensin-II antagonist, Dup 753, in the rat using the elevated plus-maze. Neuroreport 3,922-924[Medline]
  15. Mullins, J. J., Peters, J., Ganten, D. (1990) Fulminant hypertension in rats harbouring the mouse ren-2 gene. Nature (London) 344,541-544[Medline]
  16. Zhao, Y., Bader, M., Kreutz, R., Fernandez-Alfonso, M., Zimmermann, F., Ganten, U., Metzger, R., Ganten, D., Mullins, J. J., Peters, J. (1993) Ontogenetic regulation of mouse Ren-2d renin gene in transgenic hypertensive rats. Am. J. Physiol. 265,E699-E707[Abstract/Free Full Text]
  17. Campbell, D. J., Rong, P., Kladis, A., Rees, B., Ganten, D., Skinner, S. L. (1995) Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension 25,1014-1020[Abstract/Free Full Text]
  18. Senanayake, P. D., Moriguchi, A., Kumagai, H., Ganten, D., Ferrario, C. M., Brosnihan, K. B. (1994) Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 15,919-926[Medline]
  19. Jacinto, S. M., Mullins, J. J., Mitchell, K. D. (1999) Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats. Am. J. Physiol. Renal Physiol. 276,F315-F322[Abstract/Free Full Text]
  20. Albrecht, D., Davidowa, H. (1989) Action of urethane on dorsal lateral geniculate neurons. Brain. Res. Bull. 22,923-927[Medline]
  21. Kanashiro, C. A., Paiva, T. B., Paiva, A. C. M., Prioste, R. N., Aboulafia, J., Shimuta, S. I. (1995) Angiotensin II tachyphylaxis in the guinea pig ileum and its prevention: a pharmacological and biochemical study. J. Pharmacol. Exp. Ther. 275,1543-1550[Abstract/Free Full Text]
  22. Anderson, K. M., Murahashi, T., Dostal, D. E., Peach, M. J. (1993) Morphological and biochemical analysis of angiotensin II internalization in cultured rat aortic smooth muscle cells. Am. J. Physiol. 264,C179-C188[Abstract/Free Full Text]
  23. Harding, J. W., Felix, D. (1987) Quantification of angiotensin iontophoresis. J. Neurosci. Meth. 19,209-215[Medline]
  24. Lienard, F., Thornton, S. N., Martial, F. P., Mousseau, M. C., Galaverna, O., Meile, M. J., Nicolaidis, S. (1996) Effects of DOCA pretreatment on neuronal sensitivity and cell responsiveness to angiotensin II, in the bed nucleus of the stria terminalis in the rat. Regul. Pept. 66,59-63[Medline]
  25. von Bohlen und Halbach, O., Albrecht, D. (1998) Opposite effects of angiotensin II and IV in the lateral nucleus of the amygdala. Brain Res. Bull. 47,311-315[Medline]
  26. Chorvatova, A., Gallopayet, N., Casanova, C., Payet, M. D. (1996) Modulation of membrane-potential and ionic currents by the AT1 and AT2 receptors of angiotensin-II. Cell Signal 8,525-532[Medline]
  27. Sumners, C., Gelband, C. H. (1998) Neuronal ion channel signalling pathways: Modulation by angiotensin II. Cell. Signal. 10,303-311[Medline]
  28. Kang, J., Sumners, C., Posner, P. (1992) Modulation of net outward current in cultured neurons by angiotensin-II: involvement of AT1-receptor and AT2-receptors. Brain Res 580,317-324[Medline]
  29. Ambuhl, P., Felix, D., Imboden, H., Khosla, M. C., Ferrario, C. M. (1992) Effects of angiotensin-II and its selective antagonists on inferior olivary neurons. Regul. Pept. 41,19-26[Medline]
  30. Hicks, T. P. (1984) The history and development of microiontophoresis in experimental neurobiology. Prog. Neurobiol. 22,185-240[Medline]
  31. Albrecht, D., Broser, M., Krüger, H., Bader, M. (1997) Effects of angiotensin II and IV on lateral geniculate neurons in non-transgenic and TGR(mREN2)27 transgenic rats. Eur. J. Pharmacol. 332,53-63[Medline]
  32. Wilson, W., Voigt, P., Bader, M., Marsden, C. A., Fink, H. (1996) Behaviour of the transgenic (mREN2)27 rat. Brain. Res. 729,1-9[Medline]
  33. Okuyama, S., Sakagawa, T., Chaki, S., Imagawa, Y., Ichiki, T. (1999) Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor. Brain Res 821,150-159[Medline]
  34. Albrecht, D., Henklein, P., Ganten, D. (1997) Angiotensin and lisinopril actions on thalamic somatosensory neurons in normotensive, non-transgenic and hypertensive, transgenic rats. J. Hypertens. 15,1151-1157[Medline]
  35. Chan, R. K., Chan, Y. S., Wong, T. M. (1991) Responses of cardiovascular neurons in the rostral ventrolateral medulla of the normotensive Wistar Kyoto and spontaneously hypertensive rats to iontophoretic application of angiotensin II. Brain Res 556,145-150[Medline]
  36. Sanvitto, G. L., Jöhren, O., Haeuser, W., Saavedra, J. M. (1997) Water deprivation upregulates ANG II AT1 binding and mRNA in rat subfornical organ and anterior pituitary. Am. J. Physiol. Endocrinol. Metab. 273,E156-E163[Abstract/Free Full Text]
  37. von Bohlen und Halbach, O., Albrecht, D. (1998) Visualization of specific angiotensin II binding sites in the rat limbic system. Neuropeptides 32,241-245[Medline]
  38. Swanson, L. W., Petrovich, G. D. (1998) What is the amygdala?. Trends Neurosci 21,323-331[Medline]
  39. LeDoux, J. E. (1992) Brain mechanisms of emotion and emotional learning. Curr. Opin. Neurobiol. 2,191-197[Medline]



This article has been cited by other articles:


Home page
Learn. Mem.Home page
D. Albrecht
Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO
Learn. Mem., March 8, 2007; 14(3): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
D. ALBRECHT, K. HELLNER, T. WALTHER, and O. VON BOHLEN UND HALBACH
Angiotensin II and the Amygdala
Ann. N.Y. Acad. Sci., April 1, 2003; 985(1): 498 - 500.
[Full Text] [PDF]


Home page
HypertensionHome page
C. Sun, C. Sumners, and M. K. Raizada
Chronotropic Action of Angiotensin II in Neurons via Protein Kinase C and CaMKII
Hypertension, February 1, 2002; 39(2): 562 - 566.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ALBRECHT, D.
Right arrow Articles by VON BOHLEN UND HALBACH, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ALBRECHT, D.
Right arrow Articles by VON BOHLEN UND HALBACH, O.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS